Panacea Biotec Limited
₹330.1+0.90%Apr 13, 3:45 PM IST
PANACEABIO•Health Technology•Pharmaceuticals: Major
Current Price
₹330.1+0.90%
Apr 13, 3:45 PM ISTMarket Cap₹1,996.77 Cr
Market Cap₹1,996.77 Cr
Business Overview
Panacea Biotec Limited operates through 2 main business divisions including Vaccines Business, Pharmaceutical Formulations and Nutrition Business.
Business Hierarchy Structure for Panacea Biotec Limited
- Panacea Biotec Limited
- Vaccines Business
- Paediatric Vaccines Franchise
- Hexavalent Vaccine
- EasySix®
- Pentavalent Vaccine
- EasyFourPol®
- Tetravalent Dengue Vaccine
- DengiAll®
- Td Vaccine
- TedShot®
- 11-valent Pneumococcal Vaccine
- NucoVac®11
- Other Vaccines
- Hepatitis A Vaccine
- Typhoid Conjugate Vaccine
- Betacoronavirus Vaccine Candidate
- Oral Polio Vaccines (mOPVs, bOPV, Bi-OPV®)
- Easyfive-TT® (Pentavalent vaccine)
- Easyfour-TT® (Tetravalent vaccine)
- Hexavalent Vaccine
- Global Vaccine Business
- Supplies to UNICEF
- Supplies to PAHO
- Supplies to National Governments
- Pipeline Vaccines
- DengiAll®
- NucoVac®11
- Betacoronavirus Vaccine Candidate
- Paediatric Vaccines Franchise
- Pharmaceutical Formulations and Nutrition Business
- Pharmaceutical Formulations
- Prescription Products
- Transplantation
- Renal Disease
- Oncology
- Respiratory
- Pain Management
- Diabetes
- Gastro-intestinal Care
- Generic Products
- Paclitaxel protein bound in human albumin particles (PacliALL®)
- Valgapan (valganciclovir powder for oral suspension)
- Prescription Products
- Nutrition Business (7N Food & Nutrition SBU)
- Paediatric Nutrition Products (ChilRun® range)
- ChilRunfull®
- ChilRun®7+
- ChilRun®No Sucrose
- Paediatric Nutrition Products (ChilRun® range)
- Pharmaceutical Formulations
- Vaccines Business